The following section provides information on Stada Arzneimittel AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Stada Arzneimittel AG's management and employees, unlock the full data with our company analytics monitoring tool.
Mr. Peter Goldschmidt has been the Chairman of Stada since 2018. Prior to this, he served as the President of SANDOZ US. Mr. Goldschmidt also served as Global Executive Member for Central and Eastern Europe for Sandoz. He also held senior leadership positions at Novartis Pharma in Asia and Europe.
Mr. Wolfgang Ollig has been the Chief Financial Officer of the company since 2020. Prior to this, he was the Chief Financial Officer of WSA, A.S. Mr. Ollig also served as the Chief Financial Officer of Hella KGaA Hueck & Co.
Mr. Miguel Pagan Fernandez has been the Chief Technical Officer since 2018. Prior to this, he was the Head of Global Technical Operations at SANDOZ. Mr. Fernandez also served as the Global Head of Solids & Special Tech at Novartis and Vice President of Americas Operations at Merck&Co.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer